U.S. Markets closed

Humana, CVS, and DaVita Stocks Could Benefit From Trump Overhaul of Kidney Care, Analysts Say

Josh Nathan-Kazis

Shares of dialysis company DaVita are up a day after President Trump issued an executive order that could upend kidney care in the U.S., and analysts say health-insurance companies could win, too.